Conference
MA11.04 Platinum Doublet + Durvalumab +/- Tremelimumab in Patients with Advanced NSCLC: A CCTG Phase IB Study - IND.226
Authors
Juergens R; Ellis P; Tu D; Hao D; Laurie S; Mates M; Goss G; Goffin J; Bradbury P; Tehfe M
Volume
14
Pagination
pp. s291-s292
Publisher
Elsevier
Publication Date
October 1, 2019
DOI
10.1016/j.jtho.2019.08.586
Conference proceedings
Journal of Thoracic Oncology
Issue
10
ISSN
1556-0864